AIM IMMUNOTECH INC.: Funding, Investors & Team (Oct 2026)
AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders. As a result, they have developed strong laboratory and clinical data in relation to the development of nucleic acids and natural interferon to enhance the natural antiviral defence system of the human body and aid in the development of therapeutic products designed to treat cancer and chronic diseases. The company is committed to finding co-development partners with the capital and expertise to commercialize the many potential therapeutic aspects of Ampligen.
AIM IMMUNOTECH INC. has raised $5.1M across 2 funding rounds on record, the most recent an undisclosed round of $2.7M announced in Jun 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AIM IMMUNOTECH INC. Company Profile and Key Stats
Latest funding round on record: Jun 2026.
AIM IMMUNOTECH INC. Funding Rounds
AIM IMMUNOTECH INC. raised $2.4M in an undisclosed round announced in May 2026.
1 month later, an undisclosed round of $2.7M was announced in Jun 2026.
AIM IMMUNOTECH INC. Founders and Leadership Team
Contact details for the AIM IMMUNOTECH INC. team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →AIM IMMUNOTECH INC. Funding Compared to Other Biotechnology Startups
AIM IMMUNOTECH INC.'s latest round of $2.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AIM IMMUNOTECH INC. in Biotechnology and Ocala
Companies Similar to AIM IMMUNOTECH INC.
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
AIM IMMUNOTECH INC. Funding FAQs
What does AIM IMMUNOTECH INC. do?
AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders. As a result, they have developed strong laboratory and clinical data in relation to the development of nucleic acids and natural interferon to enhance the natural antiviral defence system of the human body and aid in the development of therapeutic products designed to treat cancer and chronic diseases. The company is committed to finding co-development partners with the capital and expertise to commercialize the many potential therapeutic aspects of Ampligen.
How much funding has AIM IMMUNOTECH INC. raised?
AIM IMMUNOTECH INC. has raised $5.1M across 2 rounds on record. The most recent is an undisclosed round of $2.7M announced in Jun 2026.
When did AIM IMMUNOTECH INC. last raise funding?
AIM IMMUNOTECH INC.'s most recent funding round on record is an undisclosed round of $2.7M, announced in Jun 2026.
Who founded AIM IMMUNOTECH INC.?
FundedIQ lists David Chemerow (Founder), Diane Young (Founder) at AIM IMMUNOTECH INC..
Where is AIM IMMUNOTECH INC. headquartered?
AIM IMMUNOTECH INC. is based in Ocala, Florida, United States.
How many employees does AIM IMMUNOTECH INC. have?
AIM IMMUNOTECH INC. is in the 11-50 employee band.
How does AIM IMMUNOTECH INC.'s funding compare to other Biotechnology startups?
AIM IMMUNOTECH INC.'s latest round of $2.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AIM IMMUNOTECH INC. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AIM IMMUNOTECH INC. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.